MYRIAD GENETICS INC (MYGN)

7.77 -0.31 (-3.84%)

As of 2025-10-16 20:57:08 EST

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy (precision medicine), assess a patient's risk of disease progression and disease recurrence (precision medicine), and measure disease activity.

Traded asNasdaq: MYGN
ISINUS62855J1043
CIK0000899923
LEI52990044IHUOUMETT163
EIN870494517
SectorHealthcare
IndustryIn Vitro & In Vivo Diagnostic Substances
CEOSam Raha
Employees2,600
Fiscal Year End1231
Address322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Phone801-584-3600
Websitehttps://myriad.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
MYGNMYRIAD GENETICS INC2025-10-16 20:57:087.77-0.31-3.84
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
MYGN0000899923MYRIAD GENETICS INCUS62855J104352990044IHUOUMETT163870494517Nasdaq2835In Vitro & In Vivo Diagnostic Substances1231DE322 NORTH 2200 WESTSALT LAKE CITYUT84116UNITED STATESUS801-584-3600322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116—Healthcare1991Sam Raha2,600https://myriad.com2,221,380,71493,100,00093,044,627Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy (precision medicine), assess a patient's risk of disease progression and disease recurrence (precision medicine), and measure disease activity.2025-10-10 21:31:05
This is a preview of the latest data. Subscribe to access the full data.
MYGN Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
MYGN Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
20242,221,380,714323,400,73817.039291,309,0641,434,1781.5957
20231,897,979,976432,884,48929.546589,874,8868,651,17310.651
20221,465,095,487-911,791,250-38.360781,223,7131,200,8281.5006
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Samraat S. RahaChief Operating Officer2024750,00002,910,681706,50022,1464,389,327
Mark S. VerrattiChief Commercial Officer2024552,34402,646,082489,72024,0723,712,217
Paul J. DiazChief Executive Officer, President20241,120,875011,113,5141,356,75039,46113,630,599
R. Bryan RiggsbeeChief Financial Officer202470,55500049,296119,851
Dale MuzzeyChief Scientific Officer2024499,35002,222,701265,10018,7273,005,878
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
20242,700
20232,700
20222,600
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue837,600,000753,200,000678,400,000
Cost Of Revenue252,200,000236,200,000202,000,000
Gross Profit585,400,000——
Research And Development Expenses113,400,00088,700,00085,400,000
General And Administrative Expenses275,900,000572,900,000514,700,000
Operating Expenses708,900,0001,010,600,000819,000,000
Operating Income-123,500,000-257,400,000-140,600,000
Net Income-127,300,000-263,300,000-112,000,000
Earnings Per Share Basic-1.41-3.18-1.39
Earnings Per Share Diluted-1.41-3.18-1.39
Weighted Average Shares Outstanding Basic90,600,00082,800,00080,600,000
Weighted Average Shares Outstanding Diluted90,600,00082,800,00080,600,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents102,400,000132,100,00056,900,000
Marketable Securities Current08,800,00058,000,000
Accounts Receivable121,200,000114,300,000101,600,000
Inventories27,500,00022,000,00020,100,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current298,000,000313,600,000274,600,000
Marketable Securities Non Current—054,800,000
Property Plant And Equipment117,400,000119,000,00083,400,000
Other Assets Non Current8,500,00015,400,00015,500,000
Total Assets Non Current729,500,000832,900,000924,100,000
Total Assets1,027,600,0001,146,500,0001,198,700,000
Accounts Payable32,300,00025,800,00028,800,000
Deferred Revenue—500,000600,000
Short Term Debt———
Other Liabilities Current119,000,000113,900,00094,300,000
Total Liabilities Current164,100,000155,900,000137,200,000
Long Term Debt39,600,00038,500,0000
Other Liabilities Non Current2,200,00041,300,00014,500,000
Total Liabilities Non Current162,400,000207,400,000175,700,000
Total Liabilities326,500,000363,300,000312,900,000
Common Stock900,000900,000800,000
Retained Earnings-756,800,000-629,500,000-366,200,000
Accumulated Other Comprehensive Income-800,000-3,700,000-8,900,000
Total Shareholders Equity701,100,000783,200,000885,800,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization61,200,00061,900,00052,700,000
Share Based Compensation Expense49,800,00040,700,00038,100,000
Other Non Cash Income Expense———
Change In Accounts Receivable8,700,00012,500,00010,300,000
Change In Inventories6,200,0001,800,0002,900,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable4,700,000-3,700,000-3,500,000
Change In Other Liabilities-41,000,00027,400,000-81,200,000
Cash From Operating Activities-8,700,000-110,900,000-106,300,000
Purchases Of Marketable Securities00103,200,000
Sales Of Marketable Securities9,000,00090,400,00028,400,000
Acquisition Of Property Plant And Equipment——45,300,000
Acquisition Of Business0057,200,000
Other Investing Activities———
Cash From Investing Activities-11,900,00031,900,000-77,500,000
Tax Withholding For Share Based Compensation13,400,0008,800,00010,600,000
Payments Of Dividends———
Issuance Of Common Stock———
Repurchase Of Common Stock———
Issuance Of Long Term Debt———
Repayment Of Long Term Debt119,500,00040,000,0000
Other Financing Activities5,900,0006,000,0006,300,000
Cash From Financing Activities-7,400,000152,900,000-8,000,000
Change In Cash-29,000,00074,500,000-192,400,000
Cash At End Of Period102,400,000132,100,00056,900,000
Income Taxes Paid2,700,0001,900,0001,800,000
Interest Paid1,900,0001,400,0000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share-1.41-3.18-1.39
Price To Earnings Ratio-9.7234-6.0189-10.4388
Earnings Growth Rate-55.6604128.777297.1429
Price Earnings To Growth Ratio0.1747-0.0467-0.0351
Book Value Per Share7.73849.458910.9901
Price To Book Ratio1.77172.02351.3203
Ebitda-60,600,000-196,600,000-54,300,000
Enterprise Value1,179,326,0001,491,192,0001,112,606,000
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.05650.04920
Capital Expenditures59,600,00097,500,00092,600,000
Free Cash Flow-68,300,000-208,400,000-198,900,000
Return On Equity-0.1816-0.3362-0.1264
One Year Beta1.11311.351.4496
Three Year Beta1.36611.44041.3678
Five Year Beta1.34531.38011.3051
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Ancona MargaretEVP, Strategy & Transformation2025-09-21958D127,726
Wheeler Benjamin RichardChief Financial Officer2025-09-212,559D92,651
Munk NatalieChief Accounting Officer2025-09-21962D45,167
Verratti MarkChief Operating Officer2025-09-211,085D381,826
Fox Jennifer LynneChief Legal Officer2025-09-034,435D120,481
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Blue Trust, Inc.2025-09-301,1421587.2278
CWM, LLC2025-09-30458,00063,3257.2325
Inspire Investing, LLC2025-09-30576,13379,6867.23
YOUSIF CAPITAL MANAGEMENT, LLC2025-09-30209,73529,0097.23
Farther Finance Advisors, LLC2025-09-3021,5672,9837.23
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
DFA INVESTMENT DIMENSIONS GROUP INC2025-07-31U.S. CORE EQUITY 2 PORTFOLIO - INSTITUTIONAL CLASSDFQTX116,426447,075.840.0013
DFA INVESTMENT DIMENSIONS GROUP INC2025-07-31U.S. VECTOR EQUITY PORTFOLIO - INSTITUTIONAL CLASSDFVEX19,15473,551.360.0015
Dimensional ETF Trust2025-07-31Dimensional U.S. Small Cap ETFDFAS236,160906,854.40.0087
Dimensional ETF Trust2025-07-31Dimensional US Core Equity Market ETFDFAU17,92468,828.160.0008
Dimensional ETF Trust2025-07-31Dimensional U.S. Targeted Value ETFDFAT150,985579,782.40.0054
This is a preview of the latest data. Subscribe to access the full data.